:T

Anthony C Buzzai1, Thomas Tüting1

  • 1Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital and Health Campus Immunology Infectiology and Inflammation (GC-I3), Otto-von-Guericke-University, Magdeburg, Germany.

Immunity
|October 9, 2024
PubMed
概括

使用瘤透淋巴细胞 (TIL-ACT) 的采用细胞疗法 (ACT) 是有前途的. 这项研究比较了响应和不响应TIL-ACT以改善癌症治疗的患者的T细胞动态.